BSETitan Biotech Ltd· Chemicals & PetrochemicalsHighNegative
Announced Thu, 24 Jul, 2025 · 15:25 IST

Notice received invoking arbitration in a disputed matter from advocate of nGenious Solutions Private Limited claiming disputed dues as per Annexure A attached herewith.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.2%Reaction day
₹90.20
prior close
₹90.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+0.1% vs market
Specialty Chemicals peers, median of 83sector-0.1%-0.1% vs sector

On the reaction day the stock moved 0.1 pts more than Nifty Microcap 250 and 0.1 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.2-0.3+0.1-0.1-0.1
Next day
-1.1-2.2+1.1-1.5+0.4
2d
-2.4-3.4+0.9-2.6+0.1
3d
-2.7-1.9-0.7-2.2-0.4
4d
-3.6-1.6-2.0-1.9-1.7
5d
-5.5-2.3-3.2-1.8-3.8
1w
+6.9-3.3+10.2-4.0+10.8
15d
+2.4-5.8+8.2-5.6+8.0
1m
+3.2-3.7+6.9-5.0+8.2
2m
+119.7-2.4+122.0-6.6+126.3
3m
+158.6-3.5+162.1-9.1+167.7
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 83Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Titan Biotech has received a notice from nGenious Solutions Private Limited invoking arbitration against the company, all its directors, and key managerial personnel. The claim is for recovery of disputed outstanding dues totalling Rs. 10,62,410 plus GST, which includes Rs. 9,13,920 as principal outstanding, Rs. 98,490 as compounded interest till 15 July 2025, and Rs. 50,000 as compensation. The disclosure has been made under SEBI Listing Regulations as a material litigation. The company has stated it will keep the stock exchange informed of further developments in the matter.

Likely market impact

The disputed amount is relatively small and unlikely to materially affect the company's financials or stock price. However, the matter involves all directors and KMPs, and any adverse arbitration outcome could carry reputational risk beyond the monetary claim.